Sign In
Buy BIO
$304.83
-1.30 (-0.425%)
At Close: Jun 03, 2026
Bio-Rad: Sartorius Portfolio Inclusion The Key Differentiator
03:45pm, Friday, 16'th Apr 2021
Bio-Rad comes on an extensive history of share price performance, backed by a robust fundamental underlie.
A Trio of Stocks With a History of Sales and Earnings Growth
01:29pm, Sunday, 11'th Apr 2021
In my opinion, investors could be interested in the three stocks listed below, as they meet the following criteria:
Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio
08:42am, Monday, 15'th Mar 2021
Investors remain optimistic about Bio-Rad (BIO) backed by strong segmental performance across geographies and robust testing portfolio.
Why Is Bio-Rad (BIO) Down 13% Since Last Earnings Report?
12:08pm, Saturday, 13'th Mar 2021
Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock?
3 High-Quality Picks for the Value Investor
10:45am, Thursday, 11'th Mar 2021
Benjamin Graham, the father of value investing, recommended to stick to stocks that have a current ratio of more than 2 and more working capital than long-term debt.
Bio-Rad to Participate in Barclays Global Healthcare Conference 2021
04:16pm, Friday, 05'th Mar 2021
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, Pre
Bio-Rad's Non-Operating Income Overstates GAAP Net Income
09:03am, Friday, 26'th Feb 2021
Non-operating income not only overstates GAAP net income but could negatively impact Bio-Rad's ability to obtain additional financing.
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q4 2020 Results - Earnings Call Transcript
11:33pm, Thursday, 11'th Feb 2021
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q4 2020 Results - Earnings Call Transcript
Bio-Rad Laboratories (BIO) Q4 Earnings and Revenues Surpass Estimates
06:56pm, Thursday, 11'th Feb 2021
Bio-Rad (BIO) delivered earnings and revenue surprises of 29.35% and 15.85%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Bio-Rad Laboratories: Q4 Earnings Insights
04:52pm, Thursday, 11'th Feb 2021
Shares of Bio-Rad Laboratories (NYSE:BIO) moved higher by 2.0% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 72.84% year over year to $4
Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results
04:20pm, Thursday, 11'th Feb 2021
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the
Earnings Preview: Bio-Rad Laboratories
10:30am, Wednesday, 10'th Feb 2021
Bio-Rad Laboratories (NYSE:BIO) unveils its next round of earnings this Thursday, February 11. Get prepared with Benzinga's ultimate preview for Bio-Rad Laboratories's Q4 earnings.
Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards?
10:36am, Friday, 05'th Feb 2021
Bio-Rad (BIO) Q4 earnings are expected to have benefited from strong sales, particularly within core PCR products, Droplet Digital PCR and Process Media.
Top Stocks for February 2021
03:25pm, Wednesday, 27'th Jan 2021
These are the stocks with the best value, fastest growth, and most momentum for February.
Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021
04:15pm, Monday, 25'th Jan 2021
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the fou
